StepStone leads $670m multi-fund healthcare restructuring
Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
- CV Deal Log
- Database
- LP search
- GP search
- Fund search
- Commitments New
- Investment Consultant search
- Placement Agent search
- Law Firm search
- Live Fundraising Chart
- Secondaries Market Data
- Investor Calendar 2026
- Update your database profile
- Law firm data submission
- Database key terms and methodology
- Fund performance methodology
- Quick Search
- News & Analysis
- Commentary
- Research & Rankings
- SI 50: the world’s top secondaries firms
- Secondaries Investor CV Deal Log
- Next Gen Leaders of Secondaries
- Secondaries Investor Advisory Survey
- Secondaries Investor Law Firm Survey
- Secondaries Investor Fundraising Reports
- Secondaries Investor’s Investor Reports
- Investor Intentions and Preferences
- Podcasts
